Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence-Reference-Cited by-同舟云学术

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence

Published:2020-02 Issue:6 Volume:99 Page:e18948
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Buonomo Antonio Riccardo,Scotto Riccardo,Coppola Carmine,Pinchera Biagio,Viceconte Giulio,Rapillo Costanza Maria,Staiano Laura,Saturnino Mariarosaria,Scarano Ferdinando,Portunato Federica,Pisaturo Mariantonietta,De Pascalis Stefania,Martini Salvatore,Tosone Grazia,Nappa Salvatore,Coppola Nicola,Gentile Ivan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference33 articles.

1. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus;Gentile;Expert Opin Investig Drugs,2014

2. MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection;Gentile;Expert Opin Investig Drugs,2014

3. The therapeutic potential of new investigational hepatitis C virus translation inhibitors;Borgia;Expert Opin Investig Drugs,2016

4. Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development;Gentile;Expert Opin Investig Drugs,2016

5. HCV direct-acting antiviral agents: the best interferon-free combinations;Schinazi;Liver Int,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study;Clinics and Research in Hepatology and Gastroenterology;2024-08

2. Personalized care approaches to hepatitis C therapy: recent advances and future directions;Expert Review of Anti-infective Therapy;2024-03-11

3. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study;Journal of Neurology;2022-02-14

4. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis;Microorganisms;2021-05-30

5. Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta‐analysis;Journal of Viral Hepatitis;2021-02-20